Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year.

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial

Abstract

Objective: This study compared the impact of 3 eicosapentaenoic acid (EPA) doses versus placebo on inflammatory biomarkers and depressive symptoms. Methods: Sixty-one unmedicated adults (75% female; 45.5 ± 13.8 years) with DSM-5 major depressive disorder (MDD), body mass index > 25 kg/m2, and plasma high-sensitivity C-reactive protein (hs-CRP) ≥ 3.0 mg/L were randomly assigned to receive EPA 1 g/d, 2 g/d, or 4 g/d or placebo for 12 weeks. Prespecified endpoints were a ≥ 0.40 effect size decrease in plasma interleukin (IL)-6, peripheral blood mononuclear cell (PBMC) cytokines, and lipopolysaccharide-stimulated tumor necrosis factor (TNF) production. Response was defined as a ≥ 50% decrease of Inventory of Depressive Symptomatology, Clinician-Rated version (IDS-C30) scores. We compared outcomes for the 3 EPA doses versus placebo. Results: In 45 completers, only median PBMC TNF decreased at 2 g/d EPA. No EPA dose produced a ≥ 0.35 effect size reduction in plasma IL-6 or mitogen-stimulated TNF. Response rates for EPA 4 g/d were 64%, versus 40% for placebo (odds ratio = 2.63; Cohen d = 0.53), 38% for EPA 1 g/d, and 36% for EPA 2 g/d (all P > .05). EPA 4 g/d showed a significant correlation between percent decrease in plasma hs-CRP and IDS-C30 symptom reduction at 12 weeks (Spearman ρ = 0.691, P = .019). Conclusions: EPA 4 g/d demonstrated a medium effect size for response rates versus placebo. This dose may alleviate MDD in overweight individuals with elevated inflammatory markers, and change in hs-CRP may be correlated with clinical response. Trial Registration: ClinicalTrials.gov identifier: NCT02553915

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.21m14074

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 67

Metadata

Authors
Mischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., Felger, J. C., Sangermano, L., Ziegler, T. R., Cusin, C., Fisher, L. B., Fava, M., & Rapaport, M. H.
Affiliations
  • Massachusetts General Hospital (US)
  • Emory University (US)
Venue
The Journal of Clinical Psychiatry
Published
2022-08-22
Volume
83
Issue
5
ISSN
  • 0160-6689 (ISSN-L)
  • 1555-2101
OpenAlex
W4292361112
Cited by
56
References
0
Citations by year
2026: 11 · 2025: 18 · 2024: 15 · 2023: 11 · 2022: 1
FWCI
6.94
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
Funders
National Center for Complementary and Integrative Health (UG3AT008857)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
eicosapentaenoic acid, omega-3 fatty acids, major depressive disorder, inflammation, C-reactive protein, interleukin-6, TNF-α, peripheral blood mononuclear cells, dose-response relationship, overweight, inflammatory markers, depressive symptoms
MeSH terms
Adult, C-Reactive Protein, Major Depressive Disorder, Docosahexaenoic Acids, Double-Blind Method, Female, Humans, Inflammation, Leukocytes, Mononuclear, Male, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Interleukin-6, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. https://app.cochat.ai/papers/10.4088/jcp.21m14074
The paper
Mischoulon, D., Dunlop, B. W., Kinkead, B., Schettler, P. J., Lamon-Fava, S., Rakofsky, J. J., Nierenberg, A. A., Clain, A. J., Crowe, T. M., Wong, A., Felger, J. C., Sangermano, L., Ziegler, T. R., Cusin, C., Fisher, L. B., Fava, M., & Rapaport, M. H. (2022). Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.21m14074

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.